{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:30:30Z","timestamp":1790735430750,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Menlo Therapeutics Inc"},{"name":"Trevi Therapeutics"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sanofi Pharmaceuticals"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016492","name":"Kiniksa Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016492","name":"Kiniksa Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"LEO Pharma"},{"name":"Menlo Therapeutics"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013671","name":"Sun Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010902","name":"Vanda Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010902","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Menlo Therapeutics Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jaad.2020.07.025","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T11:30:38Z","timestamp":1594812638000},"page":"747-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus"],"prefix":"10.1016","volume":"84","author":[{"given":"Sarina","family":"Elmariah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Chisolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn G.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Mollanazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Yosipovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jaad.2020.07.025_bib1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jdv.14570","article-title":"European Academy of Dermatology and Venereology European Prurigo Project: expert consensus on the definition, classification and terminology of chronic prurigo","volume":"32","author":"Pereira","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jaad.2020.07.025_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMe1916733","article-title":"Breaking the itch-scratch cycle in prurigo nodularis","volume":"382","author":"Kwatra","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2020.07.025_bib3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jid.2019.07.697","article-title":"Real-world prevalence of prurigo nodularis and burden of associated diseases","volume":"140","author":"Huang","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.07.025_bib4","first-page":"E88","article-title":"Inpatient burden of prurigo nodularis in the United States","volume":"6","author":"Whang","year":"2019","journal-title":"Medicines (Basel)"},{"issue":"5","key":"10.1016\/j.jaad.2020.07.025_bib5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jaad.2019.08.072","article-title":"Racial differences in dermatological conditions associated with HIV: a cross-sectional study of 4679 patients in an urban tertiary care center","volume":"82","author":"Bender","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.025_bib6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2018.04.047","article-title":"Ethnic differences and comorbidities of 909 prurigo nodularis patients","volume":"79","author":"Boozalis","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.025_bib7","first-page":"E98","article-title":"Racial and gender differences in the presentation of pruritus","volume":"6","author":"Whang","year":"2019","journal-title":"Medicines (Basel)"},{"issue":"1","key":"10.1016\/j.jaad.2020.07.025_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/bjd.18925","article-title":"Healthcare resource utilization and payer cost analysis of patients with prurigo nodularis","volume":"183","author":"Huang","year":"2020","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2020.07.025_bib9","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaad.2019.03.083","article-title":"Association between prurigo nodularis and malignancy in middle-aged adults","volume":"81","author":"Larson","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.025_bib10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/ijd.12022","article-title":"Prurigo nodularis as index symptom of (non-Hodgkin) lymphoma: ultrasound as a helpful diagnostic tool in dermatological disorders of unknown origin","volume":"54","author":"Schweda","year":"2015","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.07.025_bib11","first-page":"E4","article-title":"Association between prurigo nodularis and etiologies of peripheral neuropathy: suggesting a role for neural dysregulation in pathogenesis","volume":"7","author":"Hughes","year":"2020","journal-title":"Medicines (Basel)"},{"issue":"3","key":"10.1016\/j.jaad.2020.07.025_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jaad.2018.09.020","article-title":"A systematic review of evidence-based treatments for prurigo nodularis","volume":"80","author":"Qureshi","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2020.07.025_bib13","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/exd.13972","article-title":"How to define chronic prurigo?","volume":"28","author":"Pereira","year":"2019","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.07.025_bib14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2019.07.022","article-title":"Diagnostic and treatment algorithm for chronic nodular prurigo","volume":"82","author":"St\u00e4nder","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.025_bib15","first-page":"E97","article-title":"Diagnostic workup and evaluation of patients with prurigo nodularis","volume":"6","author":"Kwon","year":"2019","journal-title":"Medicines (Basel)"},{"issue":"7","key":"10.1016\/j.jaad.2020.07.025_bib16","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/jdv.16182","article-title":"The treatment of Kyrle's disease: a systematic review","volume":"34","author":"Forouzandeh","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2020.07.025_bib17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1600-0560.2009.01484.x","article-title":"Prurigo nodularis: systematic analysis of 58 histological criteria in 136 patients","volume":"37","author":"Weigelt","year":"2010","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2020.07.025_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaad.2019.09.007","article-title":"Analysis of real-world treatment patterns in patients with prurigo nodularis","volume":"82","author":"Huang","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2020.07.025_bib19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/13543784.2018.1548606","article-title":"Novel drugs for the treatment of chronic pruritus","volume":"27","author":"Pereira","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaad.2020.07.025_bib20","first-page":"1","article-title":"Emerging novel therapeutic agents for the treatment of patients with prurigo nodularis","author":"Maredia","year":"2020","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.jaad.2020.07.025_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2340\/00015555-2774","article-title":"Chronic prurigo of nodular type: a review","volume":"98","author":"Zeidler","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2020.07.025_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1067\/mjd.2001.110059","article-title":"Treatment of prurigo nodularis with topical capsaicin","volume":"44","author":"St\u00e4nder","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.025_bib23","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2016.10.030","article-title":"Topical ketamine-amitriptyline-lidocaine for chronic pruritus: a retrospective study assessing efficacy and tolerability","volume":"76","author":"Lee","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.025_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000355671","article-title":"Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial","volume":"227","author":"Siepmann","year":"2013","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.jaad.2020.07.025_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/tcrm.2006.2.2.213","article-title":"Treatment of pruritic diseases with topical calcineurin inhibitors","volume":"2","author":"St\u00e4nder","year":"2006","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"10.1016\/j.jaad.2020.07.025_bib26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/09546630903386606","article-title":"An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis","volume":"21","author":"Saraceno","year":"2010","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"10.1016\/j.jaad.2020.07.025_bib27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archderm.136.6.807","article-title":"Double-blind, right\/left comparison of calcipotriol ointment and betamethasone ointment in the treatment of prurigo nodularis","volume":"136","author":"Wong","year":"2000","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2020.07.025_bib28","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1524-4725.1983.tb01040.x","article-title":"Treatment of prurigo nodularis: use of cryosurgery and intralesional steroids plus lidocaine","volume":"9","author":"Stoll","year":"1983","journal-title":"J Dermatol Surg Oncol"},{"issue":"12","key":"10.1016\/j.jaad.2020.07.025_bib29","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/archderm.1984.01650480060020","article-title":"Cryotherapy improves prurigo nodularis","volume":"120","author":"Waldinger","year":"1984","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.025_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1365-2133.2010.09858.x","article-title":"Excimer laser vs. clobetasol propionate 0.05% ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot","volume":"163","author":"Brenninkmeijer","year":"2010","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2020.07.025_bib31","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1468-3083.2010.03865.x","article-title":"UVB 308-nm excimer light and bath PUVA: combination therapy is very effective in the treatment of prurigo nodularis","volume":"25","author":"Hammes","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2020.07.025_bib32","first-page":"85","article-title":"Gabapentin for the treatment of recalcitrant chronic prurigo nodularis","volume":"18","author":"Dereli","year":"2008","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.07.025_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jcpt.12005","article-title":"Treatment of prurigo nodularis with pregabalin","volume":"38","author":"Mazza","year":"2013","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.jaad.2020.07.025_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2340\/00015555-0553","article-title":"Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study","volume":"89","author":"St\u00e4nder","year":"2009","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2020.07.025_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ajd.12996","article-title":"Prurigo successfully treated with duloxetine hydrochloride","volume":"60","author":"Hashimoto","year":"2019","journal-title":"Australas J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2020.07.025_bib36","first-page":"433","article-title":"Amitriptyline as therapeutic and not symptomatic approach in the treatment of prurigo nodularis: a pilot study","volume":"141","author":"Zalaudek","year":"2006","journal-title":"G Ital Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2020.07.025_bib37","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jaad.2019.01.052","article-title":"Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial","volume":"80","author":"St\u00e4nder","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.07.025_bib38","doi-asserted-by":"crossref","first-page":"e10968","DOI":"10.1371\/journal.pone.0010968","article-title":"Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy","volume":"5","author":"St\u00e4nder","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.025_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2340\/00015555-3120","article-title":"Aprepitant in anti-histamine-refractory chronic nodular prurigo: a multicentre, randomized, double-blind, placebo-controlled, cross-over, phase-II trial (APREPRU)","volume":"99","author":"Tsianakas","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2020.07.025_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2340\/00015555-2780","article-title":"Role of substance P and its receptor neurokinin 1 in chronic prurigo: a randomized, proof-of-concept, controlled trial with topical aprepitant","volume":"98","author":"Ohanyan","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.025_bib41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/ced.12365","article-title":"Prurigo nodularis: retrospective study of 13 cases managed with methotrexate","volume":"39","author":"Spring","year":"2014","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.07.025_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/jdv.14646","article-title":"Treatment of prurigo with methotrexate: a multicentre retrospective study of 39 cases","volume":"32","author":"Klejtman","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.jaad.2020.07.025_bib43","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1610-0387.2008.06745.x","article-title":"Antipruritic effect of cyclosporine microemulsion in prurigo nodularis: results of a case series [in German]","volume":"6","author":"Siepmann","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"10.1016\/j.jaad.2020.07.025_bib44","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaad.2018.02.024","article-title":"Rapid improvement of prurigo nodularis with cyclosporine treatment","volume":"78","author":"Wiznia","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.07.025_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5021\/ad.2016.28.2.159","article-title":"Clinical efficacy and safety of naltrexone combination therapy in older patients with severe pruritus","volume":"28","author":"Lee","year":"2016","journal-title":"Ann Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.025_bib46","first-page":"533","article-title":"Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases","volume":"41","author":"Metze","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.07.025_bib47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2005.12.010","article-title":"Butorphanol for treatment of intractable pruritus","volume":"54","author":"Dawn","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.07.025_bib48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000331577","article-title":"Thalidomide in 42 patients with prurigo nodularis Hyde","volume":"223","author":"Andersen","year":"2011","journal-title":"Dermatology"},{"issue":"7","key":"10.1016\/j.jaad.2020.07.025_bib49","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archderm.140.7.845","article-title":"Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy","volume":"140","author":"Maurer","year":"2004","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.07.025_bib50","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2340\/00015555-0997","article-title":"Efficacy of thalidomide in the treatment of prurigo nodularis","volume":"91","author":"Taefehnorooz","year":"2011","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2020.07.025_bib51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1346-8138.2007.00260.x","article-title":"Treatment of idiopathic prurigo nodularis in Taiwanese patients with low-dose thalidomide","volume":"34","author":"Lan","year":"2007","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.07.025_bib52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/DER.0000000000000517","article-title":"Effectiveness of dupilumab for the treatment of generalized prurigo nodularis phenotype of adult atopic dermatitis","volume":"31","author":"Napolitano","year":"2020","journal-title":"Dermatitis"},{"issue":"3","key":"10.1016\/j.jaad.2020.07.025_bib53","first-page":"E72","article-title":"Chronic pruritus responding to dupilumab-a case series","volume":"6","author":"Zhai","year":"2019","journal-title":"Medicines (Basel)"},{"issue":"2","key":"10.1016\/j.jaad.2020.07.025_bib54","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/jdv.15957","article-title":"Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients","volume":"34","author":"Calugareanu","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2020.07.025_bib55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamadermatol.2018.3906","article-title":"Reduced itch associated with dupilumab treatment in 4 patients with prurigo nodularis","volume":"155","author":"Mollanazar","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.07.025_bib56","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1365-2133.1996.tb07964.x","article-title":"Nodular prurigo responsive to azathioprine","volume":"134","author":"Lear","year":"1996","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2020.07.025_bib57","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJMoa1908316","article-title":"Trial of nemolizumab in moderate-to-severe prurigo nodularis","volume":"382","author":"St\u00e4nder","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.07.025_bib58","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/CCID.S188070","article-title":"Treatment-resistant prurigo nodularis: challenges and solutions","volume":"12","author":"Kowalski","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.07.025_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2310\/7750.2009.08082","article-title":"Update on intralesional steroid: focus on dermatoses","volume":"14","author":"Richards","year":"2010","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.jaad.2020.07.025_bib60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.det.2019.08.008","article-title":"Phototherapy for itch","volume":"38","author":"Zhong","year":"2020","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.jaad.2020.07.025_bib62","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaad.2016.02.1237","article-title":"Gabapentin and pregabalin for the treatment of chronic pruritus","volume":"75","author":"Matsuda","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.07.025_bib64","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaad.2015.09.039","article-title":"Thalidomide for the treatment of chronic refractory pruritus","volume":"74","author":"Sharma","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.07.025_bib65","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/jamadermatol.2018.3912","article-title":"Dupilumab treatment for generalized prurigo nodularis","volume":"155","author":"Beck","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2020.07.025_bib66","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jdcr.2019.03.016","article-title":"Recalcitrant prurigo nodularis treated successfully with dupilumab","volume":"5","author":"Rambhia","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.jaad.2020.07.025_bib67","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaad.2015.05.025","article-title":"Azathioprine treatment of intractable pruritus: a retrospective review","volume":"73","author":"Maley","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.07.025_bib68","author":"Park"},{"key":"10.1016\/j.jaad.2020.07.025_bib69","first-page":"1","article-title":"Cannabinoids for the treatment of chronic refractory pruritus","author":"Khanna","year":"2019","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"10.1016\/j.jaad.2020.07.025_bib70","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jaad.2020.01.036","article-title":"Cannabinoids for the treatment of chronic pruritus: a review","volume":"82","author":"Avila","year":"2020","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220321897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220321897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:58:38Z","timestamp":1759273118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220321897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0190962220321897"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.07.025","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}